about
Therapy of hypoparathyroidism by replacement with parathyroid hormoneFracture risk associated with use of nonsteroidal anti-inflammatory drugs, acetylsalicylic acid, and acetaminophen and the effects of rheumatoid arthritis and osteoarthritisFracture risk associated with the use of morphine and opiatesVitamin D insufficiency in Greenlanders on a westernized fare: ethnic differences in calcitropic hormones between Greenlanders and DanesUse of organic nitrates and the risk of hip fracture: a population-based case-control study.Non-skeletal health effects of vitamin D supplementation: A systematic review on findings from meta-analyses summarizing trial dataDose-effect relations of loop- and thiazide-diuretics on calcium homeostasis: a randomized, double-blinded Latin-square multiple cross-over study in postmenopausal osteopenic women.Polymorphisms of muscle genes are associated with bone mass and incident osteoporotic fractures in Caucasians.Fracture risk is increased in Crohn's disease, but not in ulcerative colitisBone Indices in Thyroidectomized Patients on Long-Term Substitution Therapy with Levothyroxine Assessed by DXA and HR-pQCT.Vitamin D with calcium reduces mortality: patient level pooled analysis of 70,528 patients from eight major vitamin D trialsEffects of vitamin d on muscle function and performance: a review of evidence from randomized controlled trials.No effect of season of birth on risk of type 1 diabetes, cancer, schizophrenia and ischemic heart disease, while some variations may be seen for pneumonia and multiple sclerosis.Increased plasma concentrations of vitamin D metabolites and vitamin D binding protein in women using hormonal contraceptives: a cross-sectional studyCardiovascular drugs and bone.Bone effects of glitazones and other anti-diabetic drugs.Simvastatin does not affect vitamin d status, but low vitamin d levels are associated with dyslipidemia: results from a randomised, controlled trialEmerging anabolic treatments in osteoporosis.Nephrolithiasis and renal calcifications in primary hyperparathyroidism.PTH replacement therapy of hypoparathyroidism.Melatonin and the skeleton.Effects of smoking on severity of disease in primary hyperparathyroidism.High-dose treatment with vitamin A analogues and risk of fractures.Risk of atrial fibrillation associated with use of bisphosphonates and other drugs against osteoporosis: a cohort study.Gastric and esophagus events before and during treatment of osteoporosis.Use of bisphosphonates and raloxifene and risk of deep venous thromboembolism and pulmonary embolism.Vitamin D status, physical performance and body mass in patients surgically cured for primary hyperparathyroidism compared with healthy controls - a cross-sectional study.Socioeconomic aspects of fractures within universal public healthcare: a nationwide case-control study from Denmark.Effects of thiazide- and loop-diuretics, alone or in combination, on calcitropic hormones and biochemical bone markers: a randomized controlled study.Decreased fracture risk in users of organic nitrates: a nationwide case-control study.Loop diuretics alter the diurnal rhythm of endogenous parathyroid hormone secretion. A randomized-controlled study on the effects of loop- and thiazide-diuretics on the diurnal rhythms of calcitropic hormones and biochemical bone markers in postmenoAnxiolytics and sedatives and risk of fractures: effects of half-life.Oral bisphosphonate use increases the risk for inflammatory jaw disease: a cohort study.Statins decrease bone turnover in postmenopausal women: a cross-sectional study.Effects of vitamin D supplementation on body fat accumulation, inflammation, and metabolic risk factors in obese adults with low vitamin D levels - results from a randomized trial.BMD improvements after operation for primary hyperparathyroidism.Corticosteroid use and risk of hip fracture: a population-based case-control study in Denmark.Maternal and infant vitamin D status during the first 9 months of infant life-a cohort study.Investigations of the anti-inflammatory effects of vitamin D in adipose tissue: results from an in vitro study and a randomized controlled trial.No effect of vitamin A intake on bone mineral density and fracture risk in perimenopausal women.
P50
Q26828582-56CD3556-0C09-42CC-B078-E2ABFC8B76B3Q28200231-397A4CAC-0AFF-4A36-8EC7-34FEBED168DFQ28219351-6CD84BF6-7B4D-44B3-B4BB-7F88F7628399Q28237429-95C66D25-87B1-4263-BE2B-1DDA2779C8D4Q33786888-CC3A5645-DE51-4B57-8E85-AFADD0970BDFQ33884078-DCEE4433-BE69-43D7-BFB0-B70095F23865Q34166035-7514BA0E-2783-4C1A-A981-47A7D24E532EQ34570400-164FFDA4-C358-4F01-833D-1F8662F29646Q35358784-6F38F2D7-F3C7-40BC-8775-7972AD8FD6BEQ35890476-A567834A-1479-48D3-B94B-29DF9C62BEA4Q36134810-1E78BE31-B061-4C3E-829C-8A1577C86B60Q36443707-6348FAED-F9A9-4A48-B4FF-03007C004159Q37170327-0307912A-33E0-4407-872A-4058FF22E54AQ37235357-5084E8D6-3AF2-44EA-9A97-EBA9B64FB532Q37239566-6A2F9D60-DDAA-4619-AD75-A63EDAB7422FQ37239584-A203D75C-5223-477A-A7AA-DF60FEEC728EQ37423170-498760A8-3A3C-492F-98F1-751D9C033FD8Q37869514-764A2097-8708-4026-B795-BA787FEA8837Q37885603-B5684BCE-B1A7-415F-9986-C2B99A16EAFAQ38062849-1AEFF20F-54DB-4372-9EB1-ABAD7BB1DB86Q38110221-4C1702C2-8B88-45F6-99B8-BD73106B3364Q42878683-523E6B46-74CC-4DA6-8478-CCF1DA8A15A7Q43061076-8CDEF8DA-D663-4507-B589-A3BDCC4D0C43Q43121447-5B78957A-A5D7-4626-AC79-1FEBB74968F1Q43231235-1C4B0813-C740-4A06-9504-9759481D18FBQ43254330-F10AFA1F-E477-48BA-979B-8A46E3C15C2FQ43477256-9556AEDF-7B88-492C-A872-2180215CC4E0Q43532110-D58FBC33-1F73-4C67-9704-E7FB1B259334Q43698170-C8540BF7-8CDD-4AD0-A4F0-F82DD2695D06Q43740162-40AD0568-1FA3-400E-BD47-42FF3D89EE04Q43758697-4C97A6F1-B21E-4FF4-BD8C-6E0BEE9B1D6FQ43957169-8A4AA199-C6C4-4C70-8F79-260A43C396EBQ44050152-3581544C-0327-4DA0-824E-05E2AEB008EBQ44111068-7E3BDCBE-ECA8-45F4-8CC2-F815E7511D7DQ44214246-79596A95-16B1-4744-9496-A20D35F33528Q44217990-93F8B57F-119B-4FB3-B739-D1FB985F6ACCQ44612105-C43B9EA0-C00E-4D96-B3A0-C3D7EE1AAA9CQ44669412-459D9984-FD58-4CE7-91C2-5B675152E12EQ44806527-D00A169E-430C-4797-BB7D-E38806A84E19Q44807846-AB413B7A-3DFA-404E-9583-143B1C37B9AE
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Lars Rejnmark
@ast
Lars Rejnmark
@da
Lars Rejnmark
@de
Lars Rejnmark
@en
Lars Rejnmark
@es
Lars Rejnmark
@fo
Lars Rejnmark
@fr
Lars Rejnmark
@is
Lars Rejnmark
@kl
Lars Rejnmark
@nb
type
label
Lars Rejnmark
@ast
Lars Rejnmark
@da
Lars Rejnmark
@de
Lars Rejnmark
@en
Lars Rejnmark
@es
Lars Rejnmark
@fo
Lars Rejnmark
@fr
Lars Rejnmark
@is
Lars Rejnmark
@kl
Lars Rejnmark
@nb
altLabel
Rejnmark
@en
prefLabel
Lars Rejnmark
@ast
Lars Rejnmark
@da
Lars Rejnmark
@de
Lars Rejnmark
@en
Lars Rejnmark
@es
Lars Rejnmark
@fo
Lars Rejnmark
@fr
Lars Rejnmark
@is
Lars Rejnmark
@kl
Lars Rejnmark
@nb
P106
P1153
7003961192
P21
P31
P496
0000-0002-2152-4247